Istradefylline
Catalog No: 16070809
CAS Number: 155270-99-8
Purity: 98% by HPLC
Istradefylline (KW-6002) is a selective antagonist at the A2A receptor. It has been found to be useful in the treatment of Parkinson's disease. Istradefylline reduces dyskinesia resulting from long-term treatment with classical antiparkinson drugs such as levodopa. Istradefylline is an analog of caffeine.
For research use only. We do not sell to patients.
Chemical Information
| Name | Istradefylline |
|---|---|
| Iupac Chemical Name | 8-[(E)-2-(3,4-dimethoxyphenyl)vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione |
| Synonyms | KW6002; KW 6002 |
| Molecular Formula | C20H24N4O4 |
| Molecular Weight | 384.43 |
| Smile | COC=1C=C(C=CC1OC)/C=C/C1=NC=2N(C(N(C(C2N1C)=O)CC)=O)CC |
| InChiKey | IQVRBWUUXZMOPW-PKNBQFBNSA-N |
| InChi | InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+ |
| CAS Number | 155270-99-8 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO, not in water |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
